Second chance at sight camera makes progress
This article was originally published in Clinica
Executive Summary
A $9m US government-funded project that may provide a second chance at sight for people who have been blinded due to age-related macular degeneration or retinitis pigmentosa is making progress. Researchers said that the project has intensified since earlier this year, and is now closer to a refined device that can "actually produce vision".
You may also be interested in...
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.